Matches in Wikidata for { <http://www.wikidata.org/entity/Q37227402> ?p ?o ?g. }
- Q37227402 description "article científic" @default.
- Q37227402 description "article scientifique" @default.
- Q37227402 description "articolo scientifico" @default.
- Q37227402 description "artigo científico" @default.
- Q37227402 description "artículu científicu espublizáu en 2016" @default.
- Q37227402 description "bilimsel makale" @default.
- Q37227402 description "scientific article published on 07 January 2016" @default.
- Q37227402 description "vedecký článok" @default.
- Q37227402 description "vetenskaplig artikel" @default.
- Q37227402 description "videnskabelig artikel" @default.
- Q37227402 description "vědecký článek" @default.
- Q37227402 description "wetenschappelijk artikel" @default.
- Q37227402 description "wissenschaftlicher Artikel" @default.
- Q37227402 description "наукова стаття, опублікована в січні 2016" @default.
- Q37227402 description "научни чланак" @default.
- Q37227402 description "مقالة علمية نشرت في 07 يناير 2016" @default.
- Q37227402 name "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 name "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 name "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan." @default.
- Q37227402 type Item @default.
- Q37227402 label "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 label "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 label "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan." @default.
- Q37227402 prefLabel "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 prefLabel "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 prefLabel "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan." @default.
- Q37227402 P1433 Q37227402-A56B5181-E778-4A4A-81B9-72AB4B217368 @default.
- Q37227402 P1476 Q37227402-3A85C362-0771-4528-B455-CF472118A15F @default.
- Q37227402 P2093 Q37227402-3CE07483-58C4-4C2B-9A48-A20346DF44E4 @default.
- Q37227402 P2093 Q37227402-483752CD-BE6F-48EF-AB3A-14F4C69518C9 @default.
- Q37227402 P2093 Q37227402-57D9155C-EF46-433F-B44F-675AED46B364 @default.
- Q37227402 P2093 Q37227402-A99DAF69-8C42-4560-BD03-5B9BFA86E25F @default.
- Q37227402 P2093 Q37227402-D1F863A1-E7B8-43B1-AD5B-6565EA9BBE19 @default.
- Q37227402 P2093 Q37227402-FBDA0519-FDF1-4E0C-BCC4-B9EA9DAB6A60 @default.
- Q37227402 P2860 Q37227402-167CC694-3C36-4CE1-A9E8-4AC5D0D51C95 @default.
- Q37227402 P2860 Q37227402-1CBEC2F9-4B3D-42D4-BDCC-4ADD70E79A57 @default.
- Q37227402 P2860 Q37227402-2B181722-B822-442B-9753-673181F31F3D @default.
- Q37227402 P2860 Q37227402-2BD60243-21AD-424E-8E17-E780DAD5E8D4 @default.
- Q37227402 P2860 Q37227402-36C7044D-A49E-451C-B5B4-1E0A193D8E2C @default.
- Q37227402 P2860 Q37227402-45BD3519-756E-40E8-9F37-FBF7B4F1F0B1 @default.
- Q37227402 P2860 Q37227402-4F73EDC9-2AB5-4624-B657-82332C8919F8 @default.
- Q37227402 P2860 Q37227402-50548244-1112-4692-9856-E743FD536B7C @default.
- Q37227402 P2860 Q37227402-56FCE329-ECD5-46CA-8EE7-708AEB607210 @default.
- Q37227402 P2860 Q37227402-79234B6F-ACDD-406A-A1DE-F7C8DBE7BA49 @default.
- Q37227402 P2860 Q37227402-8176A8DD-9A8B-4F42-98F6-7709149473FE @default.
- Q37227402 P2860 Q37227402-871310A0-0DF8-4C7A-8285-ED75F0BEF8CB @default.
- Q37227402 P2860 Q37227402-8C0F3196-2125-4DCE-A174-1CFABAFF2CF1 @default.
- Q37227402 P2860 Q37227402-8D2DDCE8-E73F-43A3-A5A5-E0963470F87A @default.
- Q37227402 P2860 Q37227402-9205D02C-BD10-4596-8FC3-454BC33BC38B @default.
- Q37227402 P2860 Q37227402-9A361442-C9CF-493B-9038-15B28F0D5E50 @default.
- Q37227402 P2860 Q37227402-A4A1627F-D998-4C62-BF7C-A7FAC901AE35 @default.
- Q37227402 P2860 Q37227402-AC6E0FAB-6AA9-40E2-BCAF-59EC53133E04 @default.
- Q37227402 P2860 Q37227402-B5660DC1-9F5E-4C66-BFCD-B8177A20848E @default.
- Q37227402 P2860 Q37227402-C6319787-12B3-4BE2-AE31-B19E3FDEA36A @default.
- Q37227402 P2860 Q37227402-ECEBABA1-EAEB-4302-9BA5-7BE1B15AD01A @default.
- Q37227402 P2860 Q37227402-F9ED1CA1-8A84-4864-BF55-F00203366EEB @default.
- Q37227402 P2860 Q37227402-FF11492B-DDD9-4D71-941A-B09410788154 @default.
- Q37227402 P304 Q37227402-E5B82925-FBD6-4EE9-B0FB-EFAA1C931FFB @default.
- Q37227402 P31 Q37227402-FBF069F4-2515-4209-AF1D-24DCB897C5EF @default.
- Q37227402 P356 Q37227402-9EF624E5-528A-48B5-BD1B-60A3BE0D62D7 @default.
- Q37227402 P433 Q37227402-837D77EB-FEA1-4CA1-AB8B-BC4E6B0544AC @default.
- Q37227402 P478 Q37227402-1C081E28-660A-4FBB-BAAA-C94755D24F8B @default.
- Q37227402 P577 Q37227402-D6DA8247-0E7F-40DB-A41A-D8F7DB23951B @default.
- Q37227402 P5875 Q37227402-21E92FE0-2B45-449A-8697-8E9940838DB3 @default.
- Q37227402 P698 Q37227402-EB6B9C5D-8E85-40B1-8B15-3715B94D298B @default.
- Q37227402 P921 Q37227402-08BF1FA3-FD9F-4095-88A9-4D231CA682AE @default.
- Q37227402 P921 Q37227402-A813E10B-6265-45DC-A07D-8D2D79618791 @default.
- Q37227402 P932 Q37227402-3DB68A62-C532-45EA-B5D5-0916ED9EF5ED @default.
- Q37227402 P356 JDI.12474 @default.
- Q37227402 P698 27182033 @default.
- Q37227402 P1433 Q28207066 @default.
- Q37227402 P1476 "Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan" @default.
- Q37227402 P2093 "Chie Ito" @default.
- Q37227402 P2093 "Kaan Tunceli" @default.
- Q37227402 P2093 "Karen Kurtyka" @default.
- Q37227402 P2093 "Kim Brodovicz" @default.
- Q37227402 P2093 "Rie Nishikino" @default.
- Q37227402 P2093 "Yong Chen" @default.
- Q37227402 P2860 Q33487402 @default.
- Q37227402 P2860 Q35043805 @default.
- Q37227402 P2860 Q35069176 @default.
- Q37227402 P2860 Q35137030 @default.
- Q37227402 P2860 Q35645994 @default.
- Q37227402 P2860 Q36144501 @default.
- Q37227402 P2860 Q36234217 @default.
- Q37227402 P2860 Q36432150 @default.
- Q37227402 P2860 Q36669031 @default.
- Q37227402 P2860 Q37368835 @default.
- Q37227402 P2860 Q37606406 @default.
- Q37227402 P2860 Q38032532 @default.
- Q37227402 P2860 Q38156105 @default.
- Q37227402 P2860 Q39418578 @default.
- Q37227402 P2860 Q41650593 @default.
- Q37227402 P2860 Q42606650 @default.
- Q37227402 P2860 Q47305063 @default.
- Q37227402 P2860 Q48439563 @default.
- Q37227402 P2860 Q51237913 @default.
- Q37227402 P2860 Q51317522 @default.
- Q37227402 P2860 Q56570907 @default.
- Q37227402 P2860 Q83330010 @default.